{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:33:59Z","timestamp":1793298839540,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Chutian Elite Program of Hubei Province for Health Professionals","award":["2024-09054"],"award-info":[{"award-number":["2024-09054"]}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2022JJ80050"],"award-info":[{"award-number":["2022JJ80050"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wuhan Natural Science Foundation Exploration Program","award":["2024020801020397"],"award-info":[{"award-number":["2024020801020397"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40268-026-00540-1","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:19:47Z","timestamp":1773249587000},"page":"51-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and Evaluation of Multiple-Unit Tablets for the Controlled Release of Lornoxicam"],"prefix":"10.1007","volume":"26","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong-zhi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-chun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-yang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"11","key":"540_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112857","volume":"10","author":"AF Radu","year":"2021","unstructured":"Radu AF, Bungau SG. Management of Rheumatoid Arthritis: an overview. Cells. 2021;10(11):2857. https:\/\/doi.org\/10.3390\/cells10112857.","journal-title":"Cells"},{"key":"540_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012658","volume":"97","author":"MDG Moura","year":"2018","unstructured":"Moura MDG, Lopes LC, Silva MT, Barberato-Filho S, Motta RHL, Bergamaschi CC. Use of steroid and nonsteroidal anti-inflammatories in the treatment of Rheumatoid Arthritis: systematic review protocol. Medicine (Baltimore). 2018;97:e12658.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"540_CR3","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s12325-023-02481-6","volume":"40","author":"JM LaForge","year":"2023","unstructured":"LaForge JM, Urso K, Day JM, et al. Non-steroidal anti-inflammatory drugs: clinical implications, renal impairment risks, and AKI. Adv Ther. 2023;40(5):2082\u201396. https:\/\/doi.org\/10.1007\/s12325-023-02481-6.","journal-title":"Adv Ther"},{"issue":"12","key":"540_CR4","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1517\/14656566.2013.805745","volume":"14","author":"C Hillstrom","year":"2013","unstructured":"Hillstrom C, Jakobsson JG. Lornoxicam: pharmacology and usefulness to treat acute postoperative and musculoskeletal pain a narrative review. Expert Opin Pharmacother. 2013;14(12):1679\u201394. https:\/\/doi.org\/10.1517\/14656566.2013.805745.","journal-title":"Expert Opin Pharmacother"},{"key":"540_CR5","doi-asserted-by":"publisher","first-page":"122006","DOI":"10.1016\/j.ijpharm.2022.122006","volume":"624","author":"MB Zewail","year":"2022","unstructured":"Zewail MB, Asaad GF, Swellam SM, et al. Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation. Int J Pharm. 2022;624:122006. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122006.","journal-title":"Int J Pharm"},{"key":"540_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10353-006-0272-6","volume":"38","author":"EM Homdrum","year":"2006","unstructured":"Homdrum EM, Likar R, Nell G. Xefo\u00ae Rapid: a novel effective tool for pain treatment. Eur Surg. 2006;38:342\u201352. https:\/\/doi.org\/10.1007\/s10353-006-0272-6.","journal-title":"Eur Surg"},{"issue":"2","key":"540_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/10837450903059371","volume":"15","author":"H Yel-S","year":"2010","unstructured":"Yel-S H, Aburahma MH. Design and in vitro evaluation of novel sustained-release matrix tablets for Lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers. Pharm Dev Technol. 2010;15(2):139\u201353. https:\/\/doi.org\/10.3109\/10837450903059371.","journal-title":"Pharm Dev Technol"},{"issue":"4","key":"540_CR8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1208\/s12249-009-9336-90","volume":"10","author":"H Yel-S","year":"2009","unstructured":"Yel-S H, Aburahma MH. Design and in vitro evaluation of novel sustained-release double-layer tablets of Lornoxicam: utility of cyclodextrin and xanthan gum combination. AAPS PharmSciTech. 2009;10(4):1357\u201367. https:\/\/doi.org\/10.1208\/s12249-009-9336-90.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"540_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/03639040903170768","volume":"36","author":"H Yel-S","year":"2010","unstructured":"Yel-S H, Aburahma MH. Innovation of novel sustained release compression-coated tablets for Lornoxicam: formulation and in vitro investigations. Drug Dev Ind Pharm. 2010;36(3):337\u201349. https:\/\/doi.org\/10.1080\/03639040903170768.","journal-title":"Drug Dev Ind Pharm"},{"issue":"Pt A","key":"540_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ijbiomac.2022.04.041","volume":"209","author":"NT Tung","year":"2022","unstructured":"Tung NT, Dong TH, Tran CS, et al. Integration of lornoxicam nanocrystals into hydroxypropyl methylcellulose-based sustained release matrix to form a novel biphasic release system. Int J Biol Macromol. 2022;209(Pt A):441\u201351. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.04.041.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"540_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4103\/2231-4040.85531","volume":"2","author":"S Sathiyaraj","year":"2011","unstructured":"Sathiyaraj S, Devi RD, Hari VB. Lornoxicam gastro retentive floating matrix tablets: design and in vitro evaluation. J Adv Pharm Technol Res. 2011;2(3):156\u201362. https:\/\/doi.org\/10.4103\/2231-4040.85531.","journal-title":"J Adv Pharm Technol Res"},{"issue":"4","key":"540_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3109\/10837451003692595","volume":"16","author":"MH Aburahma","year":"2011","unstructured":"Aburahma MH, Yel-S H. Novel sustained-release fast-disintegrating multi-unit compressed tablets of Lornoxicam containing Eudragit RS coated chitosan-alginate beads. Pharm Dev Technol. 2011;16(4):316\u201330. https:\/\/doi.org\/10.3109\/10837451003692595.","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"540_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2010.05.014","volume":"147","author":"S Abdul","year":"2010","unstructured":"Abdul S, Chandewar AV, Jaiswal SB. A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS). J Control Release. 2010;147(1):2\u201316. https:\/\/doi.org\/10.1016\/j.jconrel.2010.05.014.","journal-title":"J Control Release"},{"issue":"4","key":"540_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040176","volume":"10","author":"N Al-Hashimi","year":"2018","unstructured":"Al-Hashimi N, Begg N, Alany RG, Hassanin H, Elshaer A. Oral modified release multiple-unit particulate systems: compressed pellets, microparticles and nanoparticles. Pharmaceutics. 2018;10(4):176. https:\/\/doi.org\/10.3390\/pharmaceutics10040176. (Published 2018 Oct 4).","journal-title":"Pharmaceutics"},{"issue":"1-2","key":"540_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2006.05.063","volume":"323","author":"CM Lopes","year":"2006","unstructured":"Lopes CM, Lobo JM, Pinto JF, Costa P. Compressed mini-tablets as a biphasic delivery system. Int J Pharm. 2006;323(1\u20132):93\u2013100. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.05.063.","journal-title":"Int J Pharm"},{"key":"540_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jconrel.2017.07.043","volume":"262","author":"T Chen","year":"2017","unstructured":"Chen T, Li J, Chen T, Sun CC, Zheng Y. Tablets of multi-unit pellet system for controlled drug delivery. J Control Release. 2017;262:222\u201331. https:\/\/doi.org\/10.1016\/j.jconrel.2017.07.043.","journal-title":"J Control Release"},{"issue":"2","key":"540_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1208\/s12249-017-0873-3","volume":"19","author":"X Zhang","year":"2018","unstructured":"Zhang X, Li Q, Ye M, et al. Preparation, characterization and in vitro\u2009\/\u2009in vivo evaluation of oral time-controlled release Etodolac pellets. AAPS PharmSciTech. 2018;19(2):610\u201320. https:\/\/doi.org\/10.1208\/s12249-017-0873-3.","journal-title":"AAPS PharmSciTech"},{"key":"540_CR18","first-page":"47","volume-title":"Pharmaceutical dosage form tablets","author":"AA Liebermann","year":"2008","unstructured":"Liebermann AA, Lachman L, Schwartz JB. Pharmaceutical dosage form tablets. 2nd ed. New York: Marcel Dekker Inc; 2008. p. 47\u20138.","edition":"2"},{"issue":"3","key":"540_CR19","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj060324","volume":"6","author":"P Sriamornsak","year":"2004","unstructured":"Sriamornsak P, Thirawong N, Puttipipatkhachorn S. Morphology and buoyancy of oil-entrapped calcium pectinate gel beads. AAPS J. 2004;6(3):e24. https:\/\/doi.org\/10.1208\/aapsj060324.","journal-title":"AAPS J"},{"issue":"2","key":"540_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03451","volume":"6","author":"L Pourtalebi Jahromi","year":"2020","unstructured":"Pourtalebi Jahromi L, Ghazali M, Ashrafi H, Azadi A. A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles. Heliyon. 2020;6(2):e03451. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03451. (Published 2020 Feb 28).","journal-title":"Heliyon"},{"issue":"6","key":"540_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/cben.202300027","volume":"10","author":"M Askarizadeh","year":"2023","unstructured":"Askarizadeh M, Esfandiari N, Honarvar B, Sajadian SA, Azdarpour A. Kinetic modeling to explain the release of medicine from drug delivery systems. ChemBioEng Rev. 2023;10(6):1006\u201349. https:\/\/doi.org\/10.1002\/cben.202300027.","journal-title":"ChemBioEng Rev"},{"issue":"6","key":"540_CR22","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1023\/a:1011976615750","volume":"15","author":"VP Shah","year":"1998","unstructured":"Shah VP, Tsong Y, Sathe P, et al. In vitro dissolution profile comparison statistics and analysis of the similarity factor, f2. Pharm Res. 1998;15(6):889\u201396. https:\/\/doi.org\/10.1023\/a:1011976615750.","journal-title":"Pharm Res"},{"key":"540_CR23","volume-title":"Spectrometric identification of organic compounds","author":"RM Silverstein","year":"2005","unstructured":"Silverstein RM, Webster FX, Kiemle DJ. Spectrometric identification of organic compounds. 7th ed. New York: Wiley; 2005.","edition":"7"},{"issue":"3","key":"540_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.34172\/apb.2020.050","volume":"10","author":"ASJ Ng","year":"2020","unstructured":"Ng ASJ. Evaluation of microcrystalline cellulose derived from Saccharum officinarum L. (sugarcane) leaves as a disintegrant in tablet formulations. Adv Pharm Bull. 2020;10(3):418\u201322. https:\/\/doi.org\/10.34172\/apb.2020.050.","journal-title":"Adv Pharm Bull"},{"issue":"16","key":"540_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ma16165664","volume":"16","author":"S Tasnim","year":"2023","unstructured":"Tasnim S, Tipu MFK, Rana MS, et al. Modification of bulk density, flow property and crystallinity of microcrystalline cellulose prepared from waste cotton. Materials. 2023;16(16):5664. https:\/\/doi.org\/10.3390\/ma16165664. (Published 2023 Aug 17).","journal-title":"Materials"},{"key":"540_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120715","volume":"604","author":"T Alzoubi","year":"2021","unstructured":"Alzoubi T, Martin GP, Barlow DJ, Royall PG. Stability of \u03b1-lactose monohydrate: the discovery of dehydration triggered solid-state epimerization. Int J Pharm. 2021;604:120715. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120715.","journal-title":"Int J Pharm"},{"issue":"1","key":"540_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ijpharm.2018.07.001","volume":"548","author":"RV Haware","year":"2018","unstructured":"Haware RV, Vinjamuri BP, Sarkar A, Stefik M, Stagner WC. Deciphering magnesium stearate thermotropic behavior. Int J Pharm. 2018;548(1):314\u201324. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.07.001.","journal-title":"Int J Pharm"},{"key":"540_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/9781119264408","volume-title":"Solid-state properties of pharmaceutical materials","author":"SR Byrn","year":"2017","unstructured":"Byrn SR, Zografi G, Chen X. Solid-state properties of pharmaceutical materials. 1st ed. Hoboken: Wiley; 2017.","edition":"1"},{"issue":"4","key":"540_CR29","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1208\/s12249-008-9163-4","volume":"9","author":"G Kibria","year":"2008","unstructured":"Kibria G, Roni MA, Absar MS, Jalil RU. Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D. AAPS PharmSciTech. 2008;9(4):1240\u20136. https:\/\/doi.org\/10.1208\/s12249-008-9163-4.","journal-title":"AAPS PharmSciTech"},{"issue":"1-2","key":"540_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijpharm.2018.05.061","volume":"547","author":"Y Takeuchi","year":"2018","unstructured":"Takeuchi Y, Tomita T, Kuroda J, et al. Characterization of mannitol granules and powder: a comparative study using two flowability testers. Int J Pharm. 2018;547(1\u20132):106\u201313. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.05.061.","journal-title":"Int J Pharm"},{"issue":"2","key":"540_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020587","volume":"15","author":"A Nikam","year":"2023","unstructured":"Nikam A, Sahoo PR, Musale S, Pagar RR, Paiva-Santos AC, Giram PS. A systematic overview of Eudragit\u00ae based copolymer for smart healthcare. Pharmaceutics. 2023;15(2):587. https:\/\/doi.org\/10.3390\/pharmaceutics15020587.","journal-title":"Pharmaceutics"},{"issue":"1","key":"540_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.fjps.2017.02.001","volume":"3","author":"CN Patra","year":"2017","unstructured":"Patra CN, Priya R, Swain S, Jena GK, Panigrahi KC, Ghose D. Pharmaceutical significance of Eudragit: a review. Future J Pharm Sci. 2017;3(1):33\u201345. https:\/\/doi.org\/10.1016\/j.fjps.2017.02.001.","journal-title":"Future J Pharm Sci"},{"issue":"6","key":"540_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100321","volume":"9","author":"SF Hung","year":"2014","unstructured":"Hung SF, Hsieh CM, Chen YC, Wang YC, Ho HO, Sheu MT. Characterizations of plasticized polymeric film coatings for preparing multiple-unit floating drug delivery systems (muFDDSs) with controlled-release characteristics. PLoS ONE. 2014;9(6):e100321. https:\/\/doi.org\/10.1371\/journal.pone.0100321.","journal-title":"PLoS ONE"},{"issue":"2","key":"540_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/03639048909040204","volume":"15","author":"RK Chang","year":"1989","unstructured":"Chang RK, Hsiao C. Eudragit RL and RS pseudolatices: properties and performane in pharmaceutical coating as a controlled release membrane for Theophylline pellets. Drug Dev Ind Pharm. 1989;15(2):187\u201396. https:\/\/doi.org\/10.3109\/03639048909040204.","journal-title":"Drug Dev Ind Pharm"},{"issue":"10","key":"540_CR35","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1002\/jps.24544","volume":"104","author":"S Yassin","year":"2015","unstructured":"Yassin S, Goodwin DJ, Anderson A, et al. The disintegration process in microcrystalline cellulose based tablets, part 1: influence of temperature, porosity and superdisintegrants. J Pharm Sci. 2015;104(10):3440\u201350. https:\/\/doi.org\/10.1002\/jps.24544.","journal-title":"J Pharm Sci"},{"key":"540_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104863","volume":"87","author":"Y Arash","year":"2023","unstructured":"Arash Y, Mostafa S, Ali N, Seyed KS. The relationship between molecular-structural properties and functional-related characteristics of croscarmellose sodium produced by different manufacturers. J Drug Deliv Sci Technol. 2023;87:104863. https:\/\/doi.org\/10.1016\/j.jddst.2023.104863.","journal-title":"J Drug Deliv Sci Technol"}],"container-title":["Drugs in R&amp;D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-026-00540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40268-026-00540-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-026-00540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:41:47Z","timestamp":1776066107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40268-026-00540-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1007\/s40268-026-00540-1","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"The datasets generated and\/or analyzed during the current study are not publicly available. However, the data that support the findings of this study are available from the corresponding author upon reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Conception and design of the work were performed by Hui Liu, Xiang-yang Xie, and Yuan Zeng. Material preparation, data collection, and analysis were performed by Yang Liu, Qiong-zhi Shi, Yanchen Wang, Ze-chun Long, and Man Han. The first draft of the manuscript was written by Hui Liu and Xiang-yang Xie, and all authors edited or commented on versions of the manuscript. All authors read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}